Harmony Biosciences Holdings, Inc. (HRMY)
Nasdaq: HRMY · Pharmaceutical Preparations · Plymouth Meeting, PA · filing with the SEC since 2020
Grade7.0
◀ Past 8.4● Present 6.9▶ Future 5.6
Who runs Harmony Biosciences Holdings, Inc.
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Dayno Jeffrey M.
PRESIDENT, CEO. First filing Aug 2020, latest Jan 26, 2026, 10 filings in all.
Officers reporting now
8
of 16 people with a filing in the last fifteen months
Directors reporting now
8
23 people on the record since 2020
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Budur Kumar | CHIEF MEDICAL OFFICER | Jan 2024 | Sep 18, 2026 | 7 · $3.1M |
| Mollichella Stephen M. | INT PRINCIAL FINANCIAL OFFICER | Jul 2026 | Jul 22, 2026 | none |
| Reicin Glenn | CHIEF FINANCIAL OFFICER | May 2026 | May 18, 2026 | none |
| Zaeske Adam H. | CHIEF COMMERCIAL OFFICER | Apr 2025 | Apr 9, 2026 | none |
| Anastasiou Peter | CHIEF OPERATING OFFICER | Nov 2023 | Apr 6, 2026 | none |
| Kapadia Sandip | CHIEF FINANCIAL OFFICER | Mar 2021 | Jan 28, 2026 | 4 · $1.8M |
| Dayno Jeffrey M. | PRESIDENT, CEO | Aug 2020 | Jan 26, 2026 | 2 · $1.0M |
| Serafin Andrew | CHIEF STRATEGY OFFICER | Aug 2020 | Jan 26, 2026 | none |
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Germano Geno J | director | May 2026 | May 18, 2026 | none |
| Graf R. Mark | director | Nov 2020 | May 18, 2026 | none |
| Philip Ron M | director | Apr 2025 | May 18, 2026 | none |
| Sabater Juan A. | director | Aug 2020 | May 18, 2026 | none |
| Sender Gary | director | Aug 2020 | May 18, 2026 | none |
| Szyper Linda M | director | Nov 2021 | May 18, 2026 | none |
| Ignelzi Troy A. | director | Apr 2026 | Apr 6, 2026 | none |
| Gracias Antonio J. | director | Aug 2020 | Sep 2, 2025 | none |
Owners of more than 10% of a classsales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Valor Equity Associates IV L.P. | 10% owner | Aug 2020 | Sep 2, 2025 | none |
| Valor Equity Capital IV LLC | 10% owner | Aug 2020 | Sep 2, 2025 | none |
| Valor Equity Partners IV L.P. | 10% owner | Aug 2020 | Sep 2, 2025 | none |
| Valor Equity Partners IV-A L.P. | 10% owner | Aug 2020 | Sep 2, 2025 | none |
| Valor Equity Partners IV-B L.P. | 10% owner | Aug 2020 | Sep 2, 2025 | none |
| Valor IV Pharma Holdings, LLC | 10% owner | Aug 2020 | Sep 2, 2025 | none |
| Valor Management L.P. | 10% owner | Aug 2020 | Sep 2, 2025 | none |
Earlier names on the record9, newest filing first
Dierks Jeffrey · officer · last filing Mar 2025Marshman Fund Trust II · 10% owner · last filing Nov 2024Nielsen Jack · director · last filing May 2024Wicki Andreas · director · last filing Dec 2022Jacobs John C · officer · last filing Aug 2022Aronin Jeffrey S · director · last filing Mar 2022Motley Eric L · director · last filing Jun 2021Novo Holdings A/s · 10% owner · last filing Sep 2020Drexler Susan L. · officer · last filing Aug 2020
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.